U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06991894) titled 'Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study' on May 16.
Brief Summary: The main goal of this study was to investigate the effectiveness and safety of eltrombopag (ETB) when compared to other treatments in Japanese aplastic anemia (AA) patients using data from the Medical Data Vision (MDV) hospital-based database.
Study Start Date: July 14, 2021
Study Type: OBSERVATIONAL
Condition:
Anemia, Aplastic
Recruitment Status: COMPLETED
Sponsor: Novartis Pharmaceuticals
Disclaimer: Curated by HT Syndication....